The Factors for Prolonging the Prognosis in Sorafenib Therapy for Hepatocellular Carcinoma With Extrahepatic Metastasis

Acta Hepatologica Japonica - Japan
doi 10.2957/kanzo.54.563
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Japan Society of Hepatology

Related search

Clinical Characteristics and Prognostic Factors for Advanced Hepatocellular Carcinoma With Extrahepatic Metastasis

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

The Systemic Inflammatory Response as a Prognostic Factor for Advanced Hepatocellular Carcinoma With Extrahepatic Metastasis

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?

Hepatology
MedicineHepatology
2012English

Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival and Metastasis of Hepatocellular Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

A Case of Hepatocellular Carcinoma With Disappearance of Lymph Node Metastasis After Sorafenib Administration

Acta Hepatologica Japonica
Hepatology
2015English

Positron Emission Tomography/Computer Tomography in Guidance of Extrahepatic Hepatocellular Carcinoma Metastasis Management

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy